Detection of Rubisco and mycotoxins as potential contaminants of a plantibody against the hepatitis B surface antigen purified from tobacco

Biologicals

Volumn 35, Issue 4, 2007, Pages 309-315

  Geada, Déborah ^a   Valdés, Rodolfo ^b   Escobar, Arturo ^c   Ares, Dulce M ^a   Torres, Edel ^b   Blanco, Reinaldo ^b   Ferro, Williams ^b   Dorta, Dayamí ^b   González, Marcos ^b   Alemán, María R ^b   Padilla, Sigifredo ^b   Gómez, Leonardo ^b   del Castillo, Norma ^a   Mendoza, Otto ^b   Urquiza, Dioslaida ^b   Soria, Yordanka ^b   Brito, José ^b   Leyva, Alberto ^b   Borroto, Carlos ^b   Gavilondo, Jorge V ^b  

^a Tobacco Research Institute   (Cuba)

^b CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^c National Center for Agricultural and Livestock Health   (Cuba)

Author keywords

Aflatoxins; Monoclonal antibody; Nicotiana tabacum; Plantibody; Rubisco

Indexed keywords

AFLATOXIN B1; AFLATOXIN B2; AFLATOXIN G1; AFLATOXIN G2; HEPATITIS B SURFACE ANTIGEN; MONOCLONAL ANTIBODY; MYCOTOXIN; PLANTIBODY; RIBULOSEBISPHOSPHATE CARBOXYLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PURIFICATION; ARTICLE; BIOMASS; ENZYME PURIFICATION; ENZYME SUBUNIT; IMMUNODETECTION; MOUSE; NONHUMAN; PLANT LEAF; POSTHARVEST PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TOBACCO;

AFLATOXINS; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; MICE; PLANTIBODIES; PLANTS, GENETICALLY MODIFIED; RIBULOSE-BISPHOSPHATE CARBOXYLASE; TOBACCO;

NICOTIANA OBTUSIFOLIA; NICOTIANA TABACUM;

EID: 35348879941     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2007.02.007     Document Type: Article

References (26)

1. Hiatt A., Cafferkey R., and Bowdish K. Production of antibodies in transgenic plants. Nature 342 (1989) 76-78
2. Alper J. Drug development: biotech thinking comes to academic medical center. Science 299 (2003) 1303-1305
3. Ma J.K., Hikmat B.Y., Wycoff K., Vine N.D., Chargelegue D., Yu L., et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med 4 (1998) 601
4. Daniell H., Streatfield S.J., and Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 6 (2001) 219
5. Koprowski H., and Yusibov V. The green revolution: plants as heterologous expression vectors. Vaccine 19 (2001) 2735
6. Ko K., Tekoah Y., Rudd P.M., Harvey D.J., Dwek R.A., Spitsin S., et al. Function and glycosylation of a plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci U S A 100 (2003) 8013
7. Ko K., Wei X., Crooks P.A., and Koprwski H. Elimination of alkaloids from plant-derived human monoclonal antibody. J Immunol Meth 286 (2004) 79-85
8. Wildman S.G. Along the trail of Fraction I to Rubisco (ribulose bisphosphate carboxylase-oxygenase). Photosyn Res 73 (2002) 243-250
9. Houltz R.L.A., and Portis Jr. R. The life of ribulose 1,5-bisphosphate carboxylase/oxygenase-posttranslational facts and mysteries. Arch Biochem Biophys 414 (2003) 150-158
10. Bennett J.W., and Klich M. Mycotoxins. Clin Microbiol Rev 16 (2003) 497-516
11. Efuntoye M.O. Mycotoxins of fungal strains from stored herbal plants and mycotoxin contents of Nigerian crude herbal drugs. Mycopath 147 (1999) 47-48
12. EMEA. CMPC, Points to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants, CMPC/BWP/764/02 (2002).
13. Pentón E., Muzio V., and González G.M. The hepatitis B virus (HBV) infection and its prevention by a recombinant DNA viral surface antigen (rec-HBsAg) vaccine. Biotechnol and Appl Biochem 11 (1994) 1-11
14. Ramírez N., Rodríguez M., Ayala M., Cremeta J., Pérez M., Martìnez A., et al. Expression and characterization of an anti-hepatitis B surface antigen) glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen. Biotechnol and Appl Biochem 38 (2003) 223-230
15. Valdés R., Gómez L., Padilla S., Brito J., Reyes B., Alvarez T., et al. Large-scale purification of an antibody directed against hepatitis B surface antigen from transgenic tobacco plants. Biochem Biophys Res Commun 308 (2003) 94-100
16. Ares D.M., Garcìa H., Naranjo S., and Peláez I. Caracterización parcial de las fracciones extraídas de las hojas de tabaco. Cubatabaco 1 (1999) 55-60
17. Fernandez de Cossío M.E., Valdés R., Agraz A., Perez L., Gonzalez-Griego M., Garcia G., et al. Development of a mouse monoclonal antibody for the purification of a yeast-derived recombinant hepatitis B surface antigen. Minerva Biotec 9 (1997) 76-84
18. Laemmli U.K. Cleavage of structural proteins during the assembly of head bacteriophage T4. Nature 227 (1970) 680-685
19. Lowry O.H., Rosenbroug N.J., Farr A.L., and Randal R. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
20. AOAC Official Method 990.33h: Derivatization En Natural Toxin. 49. 1111 North 19th Street Suite 210 (1995), Association of Official Chemists. Inc, Arlington, Virginia 22209
21. Stoger E., Sack M., Fischer R., and Christou P. Plantibodies: applications, advantages and bottlenecks. Plant Biotech 13 (2002) 161-166
22. Omurtag G.Z., and Yazicioglu J. Determination of fumonisins B-l and B-2 in herbal tea and medicinal plants in turkey by high-performance liquid chromatography. J Food Prot 67 (2004) 1782-1786
23. Creppy E.E. Update of survey, regulation and toxic effects of mycotoxins in Europe. Tox Lett 127 (2002) 19-28
24. Cabrera G., Cremata J., Valdés R., Garcia R., González Y., Montesino R., et al. Influence of culture conditions on the N-glycosylation of a monoclonal antibody specific for recombinant hepatitis B surface antigen. Biotechnol Appl Biochem 41-1 (2004) 67-76
25. Ankrah N.A., Rikimaru T., Ekuban F.A., and Addae M.M. Decreased cysteine and glutathione levels: possible determinants of liver toxicity risk in Ghanaian subjects. J Int Med Res 22 (1994) 171-176
26. Mycot. Internat. Legisl. . Updated 09/2004.